Introduction
Reactive oxygen species (ROS) are generated during reactions of cellular metabolism. Small amounts of ROS are able to be scavenged by the antioxidant system in mammalians. However, under certain conditions, the production of ROS is enhanced and exceeds the physiological defense afforded by the antioxidant system, resulting in the disturbance of redox homeostasis, the state of which is defined as oxidative stress. ROS, as well as other electrophilic agents are considered to be responsible for cellular dysfunction as they disrupt intact structures of biomacromolecules, leading to DNA damage, lipid peroxidation and inactivation of enzymes [1, 2] . For mankind, ROS are closely associated with a variety of pathological changes such as inflammation, necrosis, fibrosis and carcinogenesis.
While the cytotoxic and genotoxic effect of reactive intermediates derived from drugs and toxitants via biotransformation were mostly brought upon by phase Ⅰ enzymes, endogenous antioxidants and phase Ⅱ enzymes abolish chemical insults mediated by electrophilic species and thereby function as detoxication system. Growing evidence indicates that increased activities and expression level of phase Ⅱ enzymes effectively reduce various noxious stimuli and contribute to cytoprotection [3] .
Heme oxygenase-1 (HO-1) is a typical phase Ⅱ enzyme that catalyzes the breakdown of heme into equal amount of carbon monoxide (CO), biliverdin and iron. Compared with another two isoforms of heme oxygenase-HO-2 and HO-3, HO-1 tends to be "stress-responsive" as it is highly inducible by multiple stimuli including ischemia reperfusion, heavy metal, ultraviolet radiation and external toxicants [4, 5] . HO-1 deficiency or inhibition of HO-1 activity by applying porphyrin products could aggravate cellular damage, which suggests that the adaptive induction of HO-1 confers protection against oxidative stress [6, 7] .
The Glutathione s-transferases (GSTs) constitute an integral part of phase Ⅱ reactions, which catalyze the conjugation of reduced glutathione (GSH) to electrophilic centers on a broad range of endogenous and exogenous substrates. The total result of metabolism mediated by GSTs is the transformation of these substrates into more polar and hydrophilic derivatives that could be easily eliminated [8] . Such a mechanism is frequently involved in detoxification, drug metabolism and tumor resistance. In mammalian cells, the GSTs have been identified as a superfamily of multifunctional isoenzymes, which consists of eight classes: Alpha, Mu, Pi, Sigma, Kappa, Zeta, Theta and Omega [9] . The Alpha class GSTs have higher reactivity towards lipid peroxidation products such as 4-hydroxynonenal and malondialdehyde [10] .
NF-E2-related factor 2 (Nrf2), a member of basic leucine zipper (bZIP) transcription factors, is normally tethered in the cytoplasm to Kelch ECH Associating Protein 1 (Keap1). Under certain conditions, the Nrf2/Keap1 complex is disrupted, enabling translocation of Nrf2 into the nucleus [11] [12] [13] . Nrf2 heterodimerizes with small Maf protein and binds to the antioxidant response element (ARE) located in the promoter region of genes encoding various Phase Ⅱ enzymes such as γ-glutamyl cysteine synthetase (γ-GCS), Heme oxygenase-1 (HO-1), NAD(P)H:quinone reductase (NQO1), glutathione s-transferase (GST) [14, 15] . Nrf2 deficiency would significantly decrease the basal expression level of these enzymes, thereby enhance susceptibility to the toxicities of electrophiles and oxidants [16, 17] . Dimethylnitrosamine (DMN), a N-nitroso compound commonly occurring in cured food, tobacco products, alcoholic beverages as well as in industrial sewage, has potent hepatotoxicity in mammals. After oxidization catalyzed by CYP450 2E1, DMN is transformed into reactive oxygen intermediates, formaldehyde and methylating species
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with the toxic effect of lipid peroxidation and DNA alkylation in liver tissue. Lifetime exposure to DMN could cause liver fibrosis and cancer, while short term administration at high dose could induce acute liver injury with pathologic changes of dilatate sinusoid, infiltration of inflammatory cells and submassive hemorrhagic necrosis [18, 19] .
Gallic acid (3,4,5-trihydroxybenzoicacid, GA) is a natural polyphenol abundant in various plant species, in which it exists as either free or bound form. Like other phenolic acids, GA possesses important pharmacological properties including anti-allergy, antiinflammation, anti-tumor and anti-radiation. Previous studies indicated that the molecular mechanisms of cytoprotection mediated by GA lie in elevation of antioxidant enzymes, inhibition of CYP450 2E1, inhibition of nf-κb pathway [20, 21] . However, to our knowledge, whether this cytoprotection is related to HO-1 and GSTα remains poorly understood. Here, we elucidate that GA attenuates DMNinduced liver injury through Nrf2-mediated induction of HO-1 and GSTα.
Materials and Methods

Animals and reagents
Adult male Kunming mice (from the Animal Center of Dalian Medical University, Dalian, China), weighing 18-22 g were used in this experiment and they were housed under standard conditions (temperature of 22 ± 2℃, light/dark cycle of 12 h) with free access to food and water. All of the experimental protocols were performed in accordance with the local guidelines for the ethical treatment of experimental animals. GA and DMN were purchased from SigmaAldrich (St.Louis, MO, USA). All other reagents were of analytical grade and obtained from commercial sources.
Treatment of animals
Fifty Kun Ming male mice were randomly divided into five groups (n=10): control group; GA group at a dose of 100 mg/kg (H-GA group); DMN group; GA pretreatment group at a relatively low dose of 50 mg/ kg plus DMN injection (DMN+L-GA); GA pretreatment group at a relatively high dose of 100 mg/kg plus DMN injection (DMN+H-GA). GA was administered orally to mice twice daily for three consecutive days while the control group and DMN group received vehicle. Before each administration, GA was dissolved in 0.5% carboxymethylcellulose sodium. Acute liver injury was induced by a single intraperitoneal injection of DMN (30 mg/kg) twelve hours after the last oral administration. Twenty four hours later, blood sample was collected. Mice were then sacrificed and liver was quickly excised, rinsed in cold saline and stored correspondingly at appropriate conditions for different means of measurement.
Measurement of serum transaminase activities
The enzymatic activities of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) were measured using commercially available kits (Nanjing Jiancheng Corp., China) according to the manufacturer's instructions and expressed in IU/L.
Superoxide dismutase (SOD), glutathione peroxidase (GSH-px)
and total glutathione s-transferases (GSTs) activity.Liver tissues were homogenized in 9 volumes of ice-cold physiological saline, followed by centrifugation at 1200 rpm for 10 minutes at 4℃. Activities of SOD, GSH-px and GSTs in the supernatants were determined using commercial assay kits (Nanjing Jiancheng Corp,China) according to the manufacturer's instructions and expressed as U/mgprot, U/gprot, U/mgprot, respectively.
Assessment of lipid peroxidation
MDA in liver homogenate was assessed by the reaction with thiobarbituric acid(TBA) and used as an index of lipid peroxidation. The measurement was performed by using a MDA assay kit (Nanjing Jiancheng Corp, China). The result was expressed as nmol/mgprot.
Determination of reduced glutathion (GSH)
The hepatic GSH content was determined using an assay kit(Nanjing Jiancheng Corp., China).The result was given in mg/gprot.
Histopathological evaluation
Defined sections of liver tissues in all groups were fixed with 10% buffered formalin and embedded in paraffin blocks. Sections of 5-μm were cut, mounted on glass slides and stained with hematoxylin-eosin according to standard procedures. The slides were then examined under a light microscopy to assess the degree of liver damage.
Immuno histo chemical
Immuno histo chemical analysis of hepatic HO-1 Sections of liver specimens were dewaxed in xylene and gradient concentrations of ethanol, cultured in 0.3% hydrogen peroxide for 25 min to eliminate endogenous peroxidase. After heat-induced antigen retrieval, slides were blocked with normal goat serum for 15 min, then incubated overnight at 4℃ with monoclonal rabbit anti-mouse HO-1 antibody (ABCAM, 1:400 dilution). Slides were further treated with biotinylated anti-rabbit immunoglobulin as a secondary antibody for 15 min at 37℃. Afterwards, the horseradish peroxidase labeled streptomycinavidin complex was used to detect the secondary antibody. Finally, slides were stained with 3,3'-diaminobenzidine and counterstained with hematoxylin before being examined under a light microscope. The results were evaluated semi-quantitatively according to the percentage of positive cells in 5 high power fields at 400 multiple signal magnification: 0, less than 5%; 6% -25%; 26% -50%; 51% -75%; [22] .
Western blot analysis of Nrf2, HO-1 and GSTA3
To prepare the nuclear and cytosolic extracts, the liver homogenate obtained was allowed to swell on ice for 5 min, from which the supernatant was collected. Samples were centrifuged at 500 g for 3 min, the cell pellet was allowed to swell on ice for 15 min after addition of 200 μl of hypotonic buffer A. Samples were centrifuged at 16,000 g for 5 min after addition of 11 μl of hypotonic buffer B, and the supernatant containing cytosolic protein was stored at -80℃. The pellet was resuspended in hypotonic buffer C and incubated on ice for 40 min. Cellular debris was removed by centrifugation at 16,000 g for 10 min at 4℃, and the supernatant containing nuclear protein was stored at -80℃. These extracts containing certain amounts of nuclear or cytosolic protein as determined by the bicinchoninic acid (BCA) method were subjected to Western blot analysis. Equal amounts of protein samples (50 μg/well, cytoplasmic protein for HO-1 and GSTA3, nuclear protein for Nrf2) were separated on 15% SDS-polyacrylamide gels. After electrophoresis, the gels were electrotransferred onto PVDF membranes, which were then blocked with 5% skim milk in phosphatebuffered saline (PBS) containing 0.1% Tween 20 (PBS-T). After washing with TBS-T, membranes were probed overnight at 4℃ with primary antibodies for HO-1, GSTA3 and Nrf2 (all at 1:1000 dilution). GAPDH and Histone H3.1 were also detected with appropriate primary antibodies to ensure equal loading of cytoplasmic and nuclear proteins, respectively. Horseradish peroxidase-conjugated secondary antibodies (all at 1:2000 dilution) were then applied to membranes and the blot was developed with a DAB assay kit. The expression level of each protein was determined by analyzing the signal captured on the membrane using a gel imaging system.
Statistical analyses
All values are expressed as mean ± SEM. Statistical comparisons were made by means of a one-way ANOVA test, followed by StudentNewman-Keuls (SNK) test. In each case, a difference was considered significant when P was less than 0.05. All the statistics were carried out in SPSS 17.0.
Result
Activities of serum ALT and AST DMN administration caused 4-fold and 3-fold increment in serum ALT and AST activities, respectively (Table 1) . However, GA pretreatment at doses of 50 and 100 mg/kg prior to DMN challenge was observed to dose-dependently reverse the elevation in the activities of these two serum transaminases. In addition, there were no significant differences between the group treated with 100 mg/kg GA alone and the control group.
Activities of hepatic SOD and GPx
The activities of hepatic SOD and GP X in each group are shown in Table 2 . Compared with the control group, DMN administration caused significant reduction in both SOD and GP X activities, whereas this reduction was dose-dependently attenuated as a result of GA pretreatment. Significant differences could be observed between the DMN group and the group pretreated with 100 mg/kg of GA. On the other hand, administration of GA alone could significantly increase the activities of these antioxidant enzymes in normal mice when compared with those administered with vehicle alone. Figure 1 shows the degree of lipid peroxidation by measuring one of its end products, malondialdehyde (MDA). Acute DMN intoxication significantly increased the level of liver MDA. However, low-dose GA pretreatment inhibited the oxidative stress to a certain degree, although the difference was not statistically significant. High-dose GA apparently had the MDA level returned to normalcy.
MDA content in liver tissues
Level of hepatic reduced GSH
The changes in hepatic reduced GSH content of each group are depicted in Figure 2 . In comparison with the basal value of the control group, the oxidative stress caused by DMN dramatically depleted intracellular GSH; pretreatment with GA significantly altered the reduction of GSH in dose-dependent manner. GA also induced the elevation of GSH level in normal mice.
Activities of total GSTs in mice livers
The activities of total GST in liver tissues were studied in the present study. No significant difference in the enzyme activity was found between the control group and the DMN group (Table 3 ). Our data also shows that high-dose pretreatment of GA markedly enhanced the liver GST activity in DMN intoxicated mice. Similar effect was observed in mice administered with GA alone when compared with those in the control group. were commonly disrupted. Signs of karyorrhexis, nuclear pyknosis hypereosinophilic cytoplasm were obvious in the affected area. In contrast, pretreatment of GA (100 mg/kg) resulted in a significant amelioration of hepatic injury (Panel D). GA administration alone caused no appreciable changes in liver histology (Panel B).
Pathological alterations of liver tissues
Immunohistochemical analysis for hepatic HO-1
As shown in (Figures 4 and 5) samples from the DMN group as well as the GA alone treated group both showed strong brown staining in cytoplasm when compared with samples obtained from the control group. An even higher increase in the expression level of HO-1 could be observed in the group of GA pretreatment plus DMN challenge, which was possibly due to the synergistic upregulation of these two agents.
Western blot analysis for hepatic Nrf2, HO-1 and GSTA3
Because nuclear translocation of Nrf2 is responsible for the transcription of its target genes including HO-1 and GSTA3, Nrf2 protein in the nuclear extracts was evaluated. Western blot analysis showed minimal Nrf2 signals in the control group. In contrast, an evident increase of Nrf2 expression was found in the DMN group, perhaps resulting from cellular response to DMN-induced oxidative stress, since oxidative stress may lead to activation of Nrf2-ARE signaling. GA also induced nuclear accumulation of Nrf2 in normal mice. Moreover, the signals were even more reinforced in the group of GA pretreatment plus DMN challenge when compared with the DMN group ( Figure 6 ). We next examined the expression level of HO-1 and GSTA3 in liver tissues. Our results showed that the expression of these two phase 2 enzymes has a good correlation with the degree of Nrf2 translocation, indicating that Nrf2 plays an essential role in mediating the expression of HO-1 and GSTA3 in this model ( Figure 7 ).
Discussion
Chronic Liver disease is one of the leading causes of death worldwide. Acute liver failure, although rarely occurred, remains a rapidly progressive and frequently fatal condition. While dimethylnitrosamine is prevalently applied for the induction of liver cirrhosis and hepatocellular carcinoma, administration in high dose by single intraperitoneal injection could induce acute liver injury which is characterized by massive hemorrhagic necrosis that resembles human fulminant hepatitis [23] . This model is also considered to be appropriate for investigation of early events in the development of fibrosis [19, 24, 25] . Our preliminary experiments showed that a single intraperitoneal dose of DMN at 30 mg/kg could effectively induce acute liver injury and ensure the survival of all mice 24h after DMN exposure. Histological examination revealed that DMN caused widespread damage of liver morphology as evidenced by disrupted hepatic cords, karyorrhexis and nuclear pyknosis. Enhanced lipid peroxidation expressed in terms of MDA contents was also observed. Loss of the functional integrity of cell membranes further led to the leakage of transaminases into blood circulation. In addition, DMN intoxication significantly decreased cellular antioxidant defense, both enzymatic and non-enzymatic.
Gallic acid has been identified as active component in numerous herbal extracts which are traditionally used for medicinal purposes. In the present investigation, pretreatment of gallic acid exhibited a remarkable hepatoprotective effect against DMN-induced hepatic damage. Specifically, elevated transaminase activities and MDA level were decreased in GA-pretreated group. Activities of antioxidant enzymes such as SOD and GSH-px which are critical in scravenging O 2 • -were significantly enhanced. These changes were consistent with a relatively well preserved histological structure of liver specimen, namely, reduced hemorrhage and necrosis as well as less occurrence of karyorrhexis and nuclear pyknosis. Similar results were reported in previous studies in which GA exerted hepatoprotective effect against acetaminophen or CCl 4 -induced liver injury [20, 26] . While mechanistic investigations on GA-mediated hepatoprotection put much emphasis on the inhibitory effect of CYP2E1, whether this therapeutic mechanism involves the induction of phaseⅡ enzymes remains to be elucidated. HO-1 is the rate limiting enzyme which catalyzes the breakdown of heme into carbon monoxide CO),free iron and biliverdin, the latter being subsequently converted into bilirubin by biliverdin reductase (BVR). It is well documented that upregulation of HO-1 expression level plays pivotal role in cellular defense against various noxious stimuli and this cytoprotection can be attributed to its metabolic products mentioned above [3, 4] . Bilirubin, although previously regarded as useless or toxic products, has now been recognized as an important endogenous antioxidant. Thomas and coworkers demonstrated that bilirubin depletion by silencing BVR or HO-1 gene caused increased oxidative stress and damage in endothelial cell challenged by LPS [27] . CO plays a protective role in the complex web of inflammation. Briefly, CO enables the inhibition of nf-κb pathway which regulates the expression of many inflammatory genes encoding iNOS, COX-2, TNF, etc [28] . Judging from our histological sections, inflammatory response in GA-pretreated liver injury group is eminently decreased, which might imply that higher level of CO is generated due to enhanced expression of HO-1 induced by GA. Ferritin, the Fe 2+ sequestering protein, however, does not necessarily contribute to cytoprotection [29] . In our study, both western blotting and immunohistochemistry analysis showed that murine liver has the potentiality to defend against DMN intoxication by slightly increasing HO-1 level and pharmacological induction by GA further enhanced this hepatoprotection.
The GSTs are a family of broad-specificity enzymes that achieve detoxification through several distinct mechanisms, including catalytic inactivation of electrophilic agents through conjugation with GSH; glutathione peroxidase activity toward lipid peroxidation products; non-catalytic ligand binding for facilitating the intracellular transport of certain lipophilic compounds [8] . Among the GST gene families, the alpha class of GSTs has been reported to contribute to a major portion of the selenium-independent glutathione peroxidase activity towards hydroperoxides of phosphatidylcholine and fatty acid [30] . GSTα also exhibits conjugation activity towards substrates like 4-HNE, a stable lipid peroxidation product leading to secondary oxidation and adduct formation in biomacromolecules [10] . Investigations of tissue-specific expression of GST isoenzymes showed that compared with another two members of GSTα enzymes, GSTα3 is most highly expressed in mice liver [31] . Therefore, we carried out GSTα3 protein analysis and demonstrated that the inhibition of lipid peroxidation in GA-preteated liver injury group has a good correlation with increased expression of GSTα3. However, GSTα does not utilize H 2 O 2 as a substrate. Seleniumdependent GSH-px is responsible for the reduction of H 2 O 2 and several lipid hydroperoxides, generating free water and corresponding alcohols, respectively. In our study, GA enhanced selenium-dependent GSH-px activity in liver homogenate. Taken together, with more abundant GSH to utilize, elevation of total GST and GSH-px activity as well as increased expression of GSTα3 significantly inhibit DMNinduced oxidative damage in GA-pretreated liver injury group. Nrf2-ARE pathway, which plays an essential role in mediating the global expression of phase 2 and antioxidative enzyme, has recently received overwhelming research attention. Loss of nrf2 would result in severely impaired detoxifying machinery and completely abrogate the protective efficacy of chemopreventive agents [3, 16, 17, 32] . In our study, DMN group had a higher level of nuclear nrf2, which suggested that to a certain extent, cellular defense is able to act in concert to resist harmful reactive intermediates formed from DMN. Conflicting results were obtained by Kyung and coworkers who measured nuclear nrf2 level on the 15 th day after DMN acute intoxication [24] . However, Yang et al. investigated the dynamic expression of nuclear nrf2 in bile duct ligated mice over a 28-day period and found that nuclear nrf2 expression exhibited a transient increase over the first 7 days, followed by a fall for the rest of the period [33] . Because the ARE binding and transactivation is also regulated by other bZIP members, some of which (e.g., Bach1, c-maf) suppress ARE-mediated gene expression, the functional outcome depends on the balance of these proteins. Our results also showed that GA increased nuclear accumulation of Nrf2, providing extra cytoprotection for cellular defense against oxidative stress. Mechanism involved in GA-mediated induction of nuclear nrf2, confirmed by Yeh et al. in a vitro study, is associated with its influence on the p38 MAPK pathway [34] .
In conclusion, we demonstrated that pretreatment with GA attenuated DMN-induced acute liver injury, which might be attributed to its capability of inducing nrf2 translocation and subsequent expression of HO-1 and GSTα3. Post-treatment could reveal the therapeutic value, however, the interest is commonly discouraged possibly because the acute toxicity brought upon by DMN is almost fatal. In fact, to our knowledge, pretreatment is more often employed in experimental injury models, especially in acute cases. Also, pretreatment might effectively reveal the negative correlation between dietary intake of phytochemicals and the incidence of chronic diseases like cancer [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] .
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